文献速递心血管MR

采用MOLLI 5(3)3序列的心血管MRI测量心肌细胞外容积分数用于区分健康志愿者与扩张型及肥厚型心肌病患者

Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
PubMed 文献 · Clin Radiol · 2019-05-20

研究纳入40名健康志愿者、57例扩张型心肌病(DCM)患者和30例肥厚型心肌病(HCM)患者,均行1.5 T心血管MRI,包括晚期钆增强和MOLLI序列的原始及增强后T1 mapping。DCM和HCM患者的心肌原始T1时间和细胞外容积分数(ECV)均显著高于健康志愿者(p<0.001),ECV是DCM和HCM诊断的独立预测因子(OR=1.556,p<0.001和OR=1.847,p=0.001)。ECV区分DCM患者与健康志愿者的能力优于原始T1时间(AUC:0.889 vs 0.780,p=0.021),在最佳截断值下ECV识别DCM和HCM的敏感度分别为80.7%和83.3%,特异度分别为87.5%和70%。

要点

  • DCM和HCM患者心肌原始T1时间及ECV均显著高于健康志愿者(p<0.001)。
  • ECV是DCM和HCM诊断的独立预测因子(OR=1.556,p<0.001;OR=1.847,p=0.001)。
  • ECV区分DCM与健康志愿者的AUC为0.889,优于原始T1时间的0.780(p=0.021)。

核心结论

  • DCM和HCM患者ECV升高反映心肌细胞外基质扩张,心肌ECV在从健康志愿者中识别DCM和HCM患者方面提供良好的诊断性能。

研究设计与样本

  • 研究纳入40名健康志愿者、57例DCM患者和30例HCM患者,均在1.5 T MRI系统上行心血管磁共振成像,包括晚期钆增强以及采用改良Look-Locker反转恢复(MOLLI)序列采集的原始和增强后T1 mapping;ECV由原始和增强后T1时间计算;采用多变量二元逻辑回归分析和受试者工作特征(ROC)曲线分析评估与DCM和HCM临床诊断的一致性。

诊断标准与关键数值

  • 在最佳截断值下,ECV识别DCM患者的敏感度为80.7%、特异度为87.5%、阳性预测值为90.2%、阴性预测值为76.1%;ECV识别HCM患者的敏感度为83.3%、特异度为70%、阳性预测值为67.6%、阴性预测值为84.8%;ECV区分DCM患者与健康志愿者的AUC为0.889,原始T1时间为0.780(p=0.021)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To investigate the diagnostic performance of myocardial native T1 time and the extracellular volume fraction (ECV) for differentiating dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) patients from healthy volunteers.

MATERIALS AND METHODS: Forty healthy volunteers, 57 DCM patients, and 30 HCM patients were enrolled, all of whom underwent cardiovascular magnetic resonance imaging (CMRI), including late gadolinium enhancement (LGE) and native and post-contrast T1 mapping acquired with the modified Look-Locker inversion recovery (MOLLI) sequence on a 1.5 T MRI system. ECV were calculated by native and post-contrast T1 times. Multivariate binary logistic regression analyses and receiver operating characteristic (ROC) curve analyses were used to assess the concordance with the clinical diagnosis of DCM and HCM.

RESULTS: DCM and HCM patients had significantly higher myocardial native T1 times and ECVs than healthy volunteers (p<0.001). Multivariate logistic regression analyses showed that ECV was an independent predictor of DCM and HCM diagnosis (OR=1.556, p<0.001 and OR=1.847, p=0.001, respectively). ROC curve analysis indicated that ECV provided greater distinction between DCM patients and healthy volunteers than native T1 time (AUC: 0.889 versus 0.780, p=0.021). At the optimal cut-off value, ECV identified DCM and HCM patients with 80.7% and 83.3% sensitivity, 87.5% and 70% specificity, 90.2% and 67.6% positive predictive value, and 76.1% and 84.8% negative predictive value, respectively.

CONCLUSION: The increased ECV in DCM and HCM patients reflects myocardial extracellular matrix expansion. Myocardial ECV provides good diagnostic performance for identifying DCM and HCM patients from healthy volunteers.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Cui Y, Chen Y, Cao Y, et al. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients. Clin Radiol. 2019. PMID: 31122714. doi:10.1016/j.crad.2019.04.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。